Diabetic Retinopathy Market SWOT and PEST Analysis 2031
The Diabetic Retinopathy Market is expected to register a CAGR of 6.4% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by Type (Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy), Treatment (Anti-VEGF Drug, Steroid Injection, Laser Surgeries, and Vitrectomy). The report further presents analysis based on the Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Others). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Diabetic Retinopathy Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Diabetic Retinopathy Market Segmentation
Type- Proliferative Diabetic Retinopathy and Non-Proliferative Diabetic Retinopathy
- Anti-VEGF Drug
- Steroid Injection
- Laser Surgeries
- Vitrectomy
- Retail Pharmacies
- Hospital Pharmacies
- Others
Strategic Insights
Diabetic Retinopathy Market Growth Drivers- Rising prevalence of diabetes: According to the International Diabetes Federation, an estimated 642 million people are expected to be suffering from diabetes worldwide by 2040, which drives up the demand for diabetic retinopathy treatments. The increasing number of prevalent cases of diabetes is one of the major growth drivers, as diabetic retinopathy usually results from complications of the disease.
- Advancements in Technology:
Advances in technology such as artificial intelligence, machine learning, and others are going to enable the development of increasingly more accurate and efficient diagnostic tools for diabetic retinopathy. Advances in treatment options for the patient: Advances in technology also improve the treatment options for patient with diabetic retinopathy.
- Growing Awareness and Education: Growing awareness and education about all people regarding the need for regular eye examinations and early diagnosis of diabetic retinopathy are boosting demands for diabetic retinopathy treatments and services. American Diabetes Association suggests annual comprehensive eye examination by an eye doctor to patients suffering from diabetes. Presently, most health care services are actually trying to increase
- Focus on Early Detection: The focus towards early detection of diabetic retinopathy has increased due to the high advancements in technology and much awareness about increased importance of early detection. Telemedicine and mobile health application are making remote monitoring and early detection of diabetic retinopathy possible. This further contributes to the better patient outcomes with lower healthcare costs.
Personalized Medicine Approaches: Personalized medicine approaches, precision medicine is increasingly used for the treatment of diabetic retinopathy. Customized treatments based on the genetic makeup of the patient and the nature of their disease are being prescribed by different health care providers towards better patient outcomes and less treatment cost.
Advancements in Surgical Technologies: Improved surgical technologies, for example microincisional surgery or femtosecond laser-assisted cataract surgery have the potential to improve the patient outcome and enhance recovery times. Developments such as these should spur market growth, not least because of savings and improvements in patient care flowing from them.
- Combination Therapies: Involvement of combination therapies focused on several pathways involved in diabetic retinopathy is now opening new avenues in the treatment of the disease. Combination therapies are supposed to be more effective than single-agent therapies. This is likely to result in better patient outcomes along with lesser treatment costs.
Minimally Invasive Treatments: Minimally invasive treatments, such as intravitreal injections and photocoagulation, are developing and opening fresh avenues in the treatment of diabetic retinopathy. Minimally invasive treatments are much more minimalistic than the classical surgical avenues, therefore starting with minimizing the risk to the patient and faster recovery times.
Digital Health Platforms: Digital health platforms such as telemedicine and mobile health applications have facilitated the distant management of diabetic retinopathy. These platforms can optimize patient engagement and adherence to plans of care and therefore reduce healthcare costs and improve outcomes.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Diabetic Retinopathy Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Diabetic Retinopathy Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Treatment, and Distribution Channel
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina
Frequently Asked Questions
The diabetic retinopathy market is estimated to grow with a CAGR of 6.4% from 2023 to 2031
Asia-Pacific region is likely to witness the fastest growth rate during the forecast period.
The diabetic retinopathy market majorly consists of players such as Abbott Laboratories, Alimera Science, Allergan Plc among others
Personalised medicine is likely to remain the key trend during the forecast period.
The market drivers include the increasing prevalence of diabetes and rising geriatric population, which are driving the diabetic retinopathy market
North America dominated the diabetic retinopathy market in 2023
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Diabetic Retinopathy Market - By Type
1.3.2 Diabetic Retinopathy Market - By Treatment
1.3.3 Diabetic Retinopathy Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. DIABETIC RETINOPATHY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DIABETIC RETINOPATHY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. DIABETIC RETINOPATHY MARKET - GLOBAL MARKET ANALYSIS
6.1. DIABETIC RETINOPATHY - GLOBAL MARKET OVERVIEW
6.2. DIABETIC RETINOPATHY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. DIABETIC RETINOPATHY MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. PROLIFERATIVE DIABETIC RETINOPATHY AND DIABETIC MACULAR EDEMA
7.3.1. Overview
7.3.2. Proliferative Diabetic Retinopathy and Diabetic Macular Edema Market Forecast and Analysis
8. DIABETIC RETINOPATHY MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT
8.1. OVERVIEW
8.2. TREATMENT MARKET FORECASTS AND ANALYSIS
8.3. ANTI-VEGF DRUG
8.3.1. Overview
8.3.2. Anti-Vegf Drug Market Forecast and Analysis
8.4. STEROID IMPLANT
8.4.1. Overview
8.4.2. Steroid Implant Market Forecast and Analysis
8.5. LASER SURGERIES AND VITRECTOMY
8.5.1. Overview
8.5.2. Laser Surgeries and Vitrectomy Market Forecast and Analysis
9. DIABETIC RETINOPATHY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Diabetic Retinopathy Market Overview
9.1.2 North America Diabetic Retinopathy Market Forecasts and Analysis
9.1.3 North America Diabetic Retinopathy Market Forecasts and Analysis - By Type
9.1.4 North America Diabetic Retinopathy Market Forecasts and Analysis - By Treatment
9.1.5 North America Diabetic Retinopathy Market Forecasts and Analysis - By Countries
9.1.5.1 United States Diabetic Retinopathy Market
9.1.5.1.1 United States Diabetic Retinopathy Market by Type
9.1.5.1.2 United States Diabetic Retinopathy Market by Treatment
9.1.5.2 Canada Diabetic Retinopathy Market
9.1.5.2.1 Canada Diabetic Retinopathy Market by Type
9.1.5.2.2 Canada Diabetic Retinopathy Market by Treatment
9.1.5.3 Mexico Diabetic Retinopathy Market
9.1.5.3.1 Mexico Diabetic Retinopathy Market by Type
9.1.5.3.2 Mexico Diabetic Retinopathy Market by Treatment
9.1.5.4 US Diabetic Retinopathy Market
9.1.5.4.1 US Diabetic Retinopathy Market by Type
9.1.5.4.2 US Diabetic Retinopathy Market by Treatment
9.2. EUROPE
9.2.1 Europe Diabetic Retinopathy Market Overview
9.2.2 Europe Diabetic Retinopathy Market Forecasts and Analysis
9.2.3 Europe Diabetic Retinopathy Market Forecasts and Analysis - By Type
9.2.4 Europe Diabetic Retinopathy Market Forecasts and Analysis - By Treatment
9.2.5 Europe Diabetic Retinopathy Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Diabetic Retinopathy Market
9.2.5.1.1 Germany Diabetic Retinopathy Market by Type
9.2.5.1.2 Germany Diabetic Retinopathy Market by Treatment
9.2.5.2 France Diabetic Retinopathy Market
9.2.5.2.1 France Diabetic Retinopathy Market by Type
9.2.5.2.2 France Diabetic Retinopathy Market by Treatment
9.2.5.3 Italy Diabetic Retinopathy Market
9.2.5.3.1 Italy Diabetic Retinopathy Market by Type
9.2.5.3.2 Italy Diabetic Retinopathy Market by Treatment
9.2.5.4 Spain Diabetic Retinopathy Market
9.2.5.4.1 Spain Diabetic Retinopathy Market by Type
9.2.5.4.2 Spain Diabetic Retinopathy Market by Treatment
9.2.5.5 United Kingdom Diabetic Retinopathy Market
9.2.5.5.1 United Kingdom Diabetic Retinopathy Market by Type
9.2.5.5.2 United Kingdom Diabetic Retinopathy Market by Treatment
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Diabetic Retinopathy Market Overview
9.3.2 Asia-Pacific Diabetic Retinopathy Market Forecasts and Analysis
9.3.3 Asia-Pacific Diabetic Retinopathy Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Diabetic Retinopathy Market Forecasts and Analysis - By Treatment
9.3.5 Asia-Pacific Diabetic Retinopathy Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Diabetic Retinopathy Market
9.3.5.1.1 Australia Diabetic Retinopathy Market by Type
9.3.5.1.2 Australia Diabetic Retinopathy Market by Treatment
9.3.5.2 China Diabetic Retinopathy Market
9.3.5.2.1 China Diabetic Retinopathy Market by Type
9.3.5.2.2 China Diabetic Retinopathy Market by Treatment
9.3.5.3 India Diabetic Retinopathy Market
9.3.5.3.1 India Diabetic Retinopathy Market by Type
9.3.5.3.2 India Diabetic Retinopathy Market by Treatment
9.3.5.4 Japan Diabetic Retinopathy Market
9.3.5.4.1 Japan Diabetic Retinopathy Market by Type
9.3.5.4.2 Japan Diabetic Retinopathy Market by Treatment
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Diabetic Retinopathy Market Overview
9.4.2 Middle East and Africa Diabetic Retinopathy Market Forecasts and Analysis
9.4.3 Middle East and Africa Diabetic Retinopathy Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Diabetic Retinopathy Market Forecasts and Analysis - By Treatment
9.4.5 Middle East and Africa Diabetic Retinopathy Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Diabetic Retinopathy Market
9.4.5.1.1 South Africa Diabetic Retinopathy Market by Type
9.4.5.1.2 South Africa Diabetic Retinopathy Market by Treatment
9.4.5.2 Saudi Arabia Diabetic Retinopathy Market
9.4.5.2.1 Saudi Arabia Diabetic Retinopathy Market by Type
9.4.5.2.2 Saudi Arabia Diabetic Retinopathy Market by Treatment
9.4.5.3 U.A.E Diabetic Retinopathy Market
9.4.5.3.1 U.A.E Diabetic Retinopathy Market by Type
9.4.5.3.2 U.A.E Diabetic Retinopathy Market by Treatment
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Diabetic Retinopathy Market Overview
9.5.2 South and Central America Diabetic Retinopathy Market Forecasts and Analysis
9.5.3 South and Central America Diabetic Retinopathy Market Forecasts and Analysis - By Type
9.5.4 South and Central America Diabetic Retinopathy Market Forecasts and Analysis - By Treatment
9.5.5 South and Central America Diabetic Retinopathy Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Diabetic Retinopathy Market
9.5.5.1.1 Brazil Diabetic Retinopathy Market by Type
9.5.5.1.2 Brazil Diabetic Retinopathy Market by Treatment
9.5.5.2 Argentina Diabetic Retinopathy Market
9.5.5.2.1 Argentina Diabetic Retinopathy Market by Type
9.5.5.2.2 Argentina Diabetic Retinopathy Market by Treatment
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. DIABETIC RETINOPATHY MARKET, KEY COMPANY PROFILES
11.1. ABBOTT LABORATORIES
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ALIMERA SCIENCE
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ALLERGAN PLC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. AMPIO PHARMACEUTICALS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BAYER AG
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. F. HOFFMANN-LA ROCHE
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. NOVARTIS INTERNATIONAL AG
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PFIZER
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. REGENERON PHARMACEUTICALS INC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. VALEANT PHARMACEUTICAL
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies
- Abbott Laboratories
- Alimera Science
- Allergan Plc
- Ampio Pharmaceuticals
- Bayer AG
- F. Hoffmann-LA Roche
- Novartis International AG
- PFIZER
- Regeneron Pharmaceuticals Inc
- Valeant Pharmaceutical
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For